Heart

Antiplatelets

Select an Item to learn more...

Antiplatelets Profile

Heart
Overview
Food & Supplement Interactions
Side Effects & Contraindications
Patient Advice
Mechanism of Action

Scientific Names: Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Dipyridamole, Abciximab, Eptifibatide, Tirofiban

Common Brand Names (Scientific Names): Bayer Aspirin (Aspirin), Plavix (Clopidogrel), Effient (Prasugrel), Brilinta (Ticagrelor), Persantine (Dipyridamole), ReoPro (Abciximab), Integrilin (Eptifibatide), Aggrastat (Tirofiban)

System Category: Cardiovascular System

Common Uses: Prevention of arterial thrombosis, myocardial infarction, stroke, TIA, ACS management, post-PCI stent placement

Alcohol
(Beer, Wine, Spirits) +

Interaction: ⚠️ Increases bleeding risk

Layman Explanation: Alcohol can thin your blood and increase the risk of stomach bleeding with aspirin and other antiplatelets.

Scientific Explanation: Alcohol disrupts platelet function and gastric mucosa integrity, increasing gastrointestinal bleeding risk when combined with antiplatelet agents.

Clinical Advice: Limit or avoid alcohol, especially if on long-term antiplatelet therapy.

Herbal Supplements
(Ginkgo Biloba, Garlic, Ginger, Turmeric) +

Interaction: ⚠️ May increase bleeding risk

Layman Explanation: Some herbs like garlic and ginkgo thin the blood β€” which can compound the effect of antiplatelets.

Scientific Explanation: Herbal agents may exhibit antiplatelet activity and enhance bleeding risk through inhibition of platelet aggregation and coagulation pathways.

Clinical Advice: Disclose all supplement use to your healthcare provider.

Omega-3 Fatty Acids
(Fish Oil, Flaxseed) +

Interaction: 🟑 Mild increase in bleeding risk at high doses

Layman Explanation: Fish oils can slightly thin your blood and may add to the effect of antiplatelets.

Scientific Explanation: Omega-3 fatty acids reduce thromboxane A2 synthesis and inhibit platelet aggregation; caution warranted with high-dose supplementation.

Clinical Advice: Moderate dietary intake is acceptable; monitor if using high-dose supplements.

Common Side Effects

  • Increased risk of bleeding (nosebleeds, GI bleeding, bruising)
  • Gastrointestinal irritation or ulcers (especially with aspirin)
  • Headache and dizziness (especially with dipyridamole)
  • Shortness of breath (ticagrelor-specific)

Serious Risks & Contraindications

  • Active internal bleeding (e.g., peptic ulcer, intracranial hemorrhage)
  • Hypersensitivity to any antiplatelet agent
  • History of hemorrhagic stroke (in some cases)
  • Severe liver impairment (ticagrelor, prasugrel)
  • Surgery or trauma increasing bleeding risk
  • πŸ’Š Take your antiplatelet medication exactly as prescribed; never double doses if you miss one.
  • 🩸 Report any unusual bruising or signs of bleeding to your doctor immediately.
  • πŸ”ͺ Inform surgeons or dentists before any procedures β€” even dental cleanings.
  • 🍷 Avoid or limit alcohol as it may increase bleeding risk.
  • 🌿 Avoid herbal supplements that may affect clotting (e.g., ginkgo, garlic) unless approved by a provider.
  • πŸ” Do not stop antiplatelet therapy suddenly without consulting your doctor β€” especially after stent placement.

Mechanism of Action

Layman Explanation:

Antiplatelets stop your blood from forming dangerous clots by preventing blood cells (platelets) from sticking together. This helps reduce heart attack and stroke risk.

Scientific Explanation:

Aspirin: Irreversibly inhibits COX-1 enzyme in platelets, reducing thromboxane A2 synthesis and thus platelet aggregation.
Clopidogrel/Prasugrel: Irreversibly block the P2Y12 ADP receptor on platelets, inhibiting their activation and aggregation.
Ticagrelor: Reversibly inhibits the P2Y12 receptor; does not require metabolic activation.
Dipyridamole: Inhibits phosphodiesterase (PDE), increasing cAMP in platelets and reducing their activation.
GPIIb/IIIa Inhibitors: Block final common pathway for platelet aggregation by preventing fibrinogen binding to glycoprotein IIb/IIIa receptors.

Aspirin

Clopidogrel

Γ—

πŸ§ͺ Scientific Background: Antiplatelets


Drug Classes:


Pharmacokinetics Summary:


Clinical Considerations: